| Total | Germany | France | UK | Spain | Poland |
BASE: total respondents | 1513 | 301 | 304 | 300 | 308 | 300 |
Concomitant products (Frequency/Percentage) | ||||||
Paracetamol | 1148 75.9% | 176 58.5% | 264 86.8% | 233 77.7% | 254 82.5% | 221 73.7% |
MSR | 969 64.0% | 201 66.8% | 156 51.3% | 168 56.0% | 173 56.2% | 271 90.3% |
Nasal decongestants | 862 57.0% | 208 69.1% | 129 42.4% | 143 47.7% | 151 49.0% | 231 77.0% |
Most frequently used concomitant product (Frequency/Percentage) | ||||||
Paracetamol | 677 44.7% | 84 27.9% | 201 66.1% | 158 52.7% | 155 50.3% | 79 26.3% |
MSR | 550 36.4% | 117 38.9% | 61 20.1% | 98 32.7% | 102 33.1% | 172 57.3% |
Nasal decongestants | 286 18.9% | 100 33.2% | 42 13.8% | 44 14.7% | 51 16.6% | 49 16.3% |